OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Actions of Metformin in the Brain: A New Perspective of Metformin Treatments in Related Neurological Disorders
Nuojin Li, Tian Zhou, Erkang Fei
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8281-8281
Open Access | Times Cited: 41
Nuojin Li, Tian Zhou, Erkang Fei
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8281-8281
Open Access | Times Cited: 41
Showing 1-25 of 41 citing articles:
Clinical trials of new drugs for Alzheimer disease: a 2020–2023 update
Li‐Kai Huang, Yi‐Chun Kuan, Ho-Wei Lin, et al.
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 132
Li‐Kai Huang, Yi‐Chun Kuan, Ho-Wei Lin, et al.
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 132
Metformin decelerates aging clock in male monkeys
Yuan‐Han Yang, Xiaoyong Lu, Ning Liu, et al.
Cell (2024) Vol. 187, Iss. 22, pp. 6358-6378.e29
Closed Access | Times Cited: 46
Yuan‐Han Yang, Xiaoyong Lu, Ning Liu, et al.
Cell (2024) Vol. 187, Iss. 22, pp. 6358-6378.e29
Closed Access | Times Cited: 46
New insights on the potential anti‐epileptic effect of metformin: Mechanistic pathway
Saud A. Alnaaim, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 24, pp. 3953-3965
Open Access | Times Cited: 23
Saud A. Alnaaim, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 24, pp. 3953-3965
Open Access | Times Cited: 23
Identification of Parkinson’s disease PACE subtypes and repurposing treatments through integrative analyses of multimodal data
Chang Su, Yu Hou, Jielin Xu, et al.
npj Digital Medicine (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 7
Chang Su, Yu Hou, Jielin Xu, et al.
npj Digital Medicine (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 7
Metformin mitigates amyloid β1-40-induced cognitive decline via attenuation of oxidative/nitrosative stress and neuroinflammation
Mahmoud Khaleghi-Mehr, Alireza-Azizzadeh Delshad, Sepideh Shafie-Damavandi, et al.
Metabolic Brain Disease (2023) Vol. 38, Iss. 4, pp. 1127-1142
Closed Access | Times Cited: 15
Mahmoud Khaleghi-Mehr, Alireza-Azizzadeh Delshad, Sepideh Shafie-Damavandi, et al.
Metabolic Brain Disease (2023) Vol. 38, Iss. 4, pp. 1127-1142
Closed Access | Times Cited: 15
Novel Activity of Oral Hypoglycemic Agents Linked with Decreased Formation of Tryptophan Metabolite, Kynurenic Acid
Kinga Bednarz, Kamila Kozieł, Ewa M. Urbańska
Life (2024) Vol. 14, Iss. 1, pp. 127-127
Open Access | Times Cited: 5
Kinga Bednarz, Kamila Kozieł, Ewa M. Urbańska
Life (2024) Vol. 14, Iss. 1, pp. 127-127
Open Access | Times Cited: 5
The role of metformin as a treatment for neuropsychiatric illness
Seetal Dodd, Luba Sominsky, Dan Siskind, et al.
European Neuropsychopharmacology (2022) Vol. 64, pp. 32-43
Closed Access | Times Cited: 21
Seetal Dodd, Luba Sominsky, Dan Siskind, et al.
European Neuropsychopharmacology (2022) Vol. 64, pp. 32-43
Closed Access | Times Cited: 21
Metformin alleviates reactive gliosis and neurodegeneration, improving cognitive deficit in a rat model of temporal lobe epilepsy
Sree Lalitha Bojja, Shashi Anand, Ranjana W. Minz, et al.
Brain Research (2024) Vol. 1844, pp. 149138-149138
Open Access | Times Cited: 4
Sree Lalitha Bojja, Shashi Anand, Ranjana W. Minz, et al.
Brain Research (2024) Vol. 1844, pp. 149138-149138
Open Access | Times Cited: 4
Advances in the treatment of glioma-related signaling pathways and mechanisms by metformin
Xingyuan Ma, Chao Sun, Xiao Ding, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Xingyuan Ma, Chao Sun, Xiao Ding, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Metformin as a potential antidepressant: Mechanisms and therapeutic insights in depression
Yuan‐Yuan Cheng, Qi Yao, Yang Miao, et al.
Biochemical Pharmacology (2025) Vol. 233, pp. 116773-116773
Closed Access
Yuan‐Yuan Cheng, Qi Yao, Yang Miao, et al.
Biochemical Pharmacology (2025) Vol. 233, pp. 116773-116773
Closed Access
Metformin: Beyond Diabetes Management to Neuroprotection and Cognitive Enhancement
Priyanka Gupta, Sirshak Dutta, Rajiv Jash, et al.
Current Pharmacology Reports (2025) Vol. 11, Iss. 1
Closed Access
Priyanka Gupta, Sirshak Dutta, Rajiv Jash, et al.
Current Pharmacology Reports (2025) Vol. 11, Iss. 1
Closed Access
Role of mitogen-activated protein kinase inhibitors in Alzheimer's disease: Rouge of brain kinases
Suad Hamdan Almasoudi, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Brain Research Bulletin (2025) Vol. 224, pp. 111296-111296
Open Access
Suad Hamdan Almasoudi, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Brain Research Bulletin (2025) Vol. 224, pp. 111296-111296
Open Access
Overview of Metformin and Neurodegeneration: A Comprehensive Review
Weronika Kruczkowska, Julia Gałęziewska, Paulina Buczek, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 486-486
Open Access
Weronika Kruczkowska, Julia Gałęziewska, Paulina Buczek, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 486-486
Open Access
Exploring Metformin’s Therapeutic Potential for Alzheimer’s Disease: An In-Silico Perspective Using Well-Tempered Funnel Metadynamics
Sunandini Swain, Atanu K. Metya
Journal of Chemical Information and Modeling (2025)
Closed Access
Sunandini Swain, Atanu K. Metya
Journal of Chemical Information and Modeling (2025)
Closed Access
Glutamatergic dysfunction in neurodegenerative diseases focusing on Parkinson's disease: Role of glutamate modulators
Najlaa H. Almohmadi, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Brain Research Bulletin (2025), pp. 111349-111349
Open Access
Najlaa H. Almohmadi, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Brain Research Bulletin (2025), pp. 111349-111349
Open Access
Diabetes and dementia: current data
N.V. Pashkovska, V.M. Pashkovskyy
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) (2025) Vol. 21, Iss. 2, pp. 215-225
Open Access
N.V. Pashkovska, V.M. Pashkovskyy
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) (2025) Vol. 21, Iss. 2, pp. 215-225
Open Access
Nerolidol rescues hippocampal injury of diabetic rats through inhibiting NLRP3 inflammasome and regulation of MAPK /AKT pathway
Yining Lei, Manqin Li, Xinran Liu, et al.
BioFactors (2024)
Closed Access | Times Cited: 3
Yining Lei, Manqin Li, Xinran Liu, et al.
BioFactors (2024)
Closed Access | Times Cited: 3
Promising new pharmacological targets for depression: The search for efficacy
Lucila Emiko Tsugiyama, Ruan Carlos Macêdo de Moraes, Yaslle Andrade Cavalcante Moraes, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 12, pp. 103804-103804
Closed Access | Times Cited: 8
Lucila Emiko Tsugiyama, Ruan Carlos Macêdo de Moraes, Yaslle Andrade Cavalcante Moraes, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 12, pp. 103804-103804
Closed Access | Times Cited: 8
Repurposing metformin to manage idiopathic or long COVID Tinnitus: self-report adopting a pathophysiological and pharmacological approach
Mina Kelleni
Inflammopharmacology (2024) Vol. 32, Iss. 2, pp. 945-948
Open Access | Times Cited: 2
Mina Kelleni
Inflammopharmacology (2024) Vol. 32, Iss. 2, pp. 945-948
Open Access | Times Cited: 2
Metformin Induces MeCP2 in the Hippocampus of Male Mice with Sex-Specific and Brain-Region-Dependent Molecular Impact
Khatereh Saei Arezoumand, Chris-Tiann Roberts, Mojgan Rastegar
Biomolecules (2024) Vol. 14, Iss. 4, pp. 505-505
Open Access | Times Cited: 2
Khatereh Saei Arezoumand, Chris-Tiann Roberts, Mojgan Rastegar
Biomolecules (2024) Vol. 14, Iss. 4, pp. 505-505
Open Access | Times Cited: 2
Exploring the clinical connections between epilepsy and diabetes mellitus: Promising therapeutic strategies utilizing agmatine and metformin
Aayushi Nangia, Janani Srividya Saravanan, Shruti Hazra, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 2
Aayushi Nangia, Janani Srividya Saravanan, Shruti Hazra, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 2
Cognitive impairment in type 2 diabetes mellitus: prospects for the use of metformin
N.V. Pashkovska
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) (2023) Vol. 19, Iss. 3, pp. 215-224
Open Access | Times Cited: 6
N.V. Pashkovska
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) (2023) Vol. 19, Iss. 3, pp. 215-224
Open Access | Times Cited: 6
Metformin Improves Comorbid Depressive Symptoms in Mice with Allergic Rhinitis by Reducing Olfactory Bulb Damage
Hao Lv, Ziang Gao, Yunfei Wang, et al.
Neurochemical Research (2023) Vol. 48, Iss. 12, pp. 3639-3651
Closed Access | Times Cited: 6
Hao Lv, Ziang Gao, Yunfei Wang, et al.
Neurochemical Research (2023) Vol. 48, Iss. 12, pp. 3639-3651
Closed Access | Times Cited: 6
Pharmacological management of fragile X syndrome: a systematic review and narrative summary of the current evidence
Lance Watkins, Seungyoun Moon, Lisa Burrows, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 3, pp. 301-313
Open Access | Times Cited: 1
Lance Watkins, Seungyoun Moon, Lisa Burrows, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 3, pp. 301-313
Open Access | Times Cited: 1
Beneficial effects of metformin treatment on memory impairment
Mohammad Pourfridoni, Mahdiyeh Hedayati‐Moghadam, Shirin Fathi, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 1
Mohammad Pourfridoni, Mahdiyeh Hedayati‐Moghadam, Shirin Fathi, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 1
